Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial

Conclusions
In treatment-naive haemodialysis patients with HCV-2 infection, combination therapy with peginterferon plus low-dose ribavirin achieved a greater SVR rate than peginterferon monotherapy. Most haemodialysis patients can tolerate combination therapy.

Trial registration number
ClinicalTrial.gov number, NCT00491244.

Source: Gut - January 8, 2015 Category: Gastroenterology Authors: Liu, C.-H., Liu, C.-J., Huang, C.-F., Lin, J.-W., Dai, C.-Y., Liang, C.-C., Huang, J.-F., Hung, P.-H., Tsai, H.-B., Tsai, M.-K., Lee, C.-Y., Chen, S.-I., Yang, S.-S., Su, T.-H., Yang, H.-C., Chen, P.-J., Chen, D.-S., Chuang, W.-L., Yu, M.-L., Kao, J.-H. Tags: Hepatology Source Type: research